✦ LIBER ✦

Serum osteoprotegerin is a predictor for incident cardiovascular disease and mortality in a general population: the Tromsø Study

✍ Scribed by A. VIK; E. B. MATHIESEN; J. BROX; T. WILSGAARD; I. NJØLSTAD; L. JØRGENSEN; J.-B. HANSEN

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Serum osteoprotegerin, sRANKL and caroti

✍ A. VIK; E. B. MATHIESEN; S. H. JOHNSEN; J. BROX; T. WILSGAARD; I. NJØLSTAD; J.-B 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 153 KB

Relation between serum osteoprotegerin a

✍ A. VIK; E. B. MATHIESEN; J. BROX; T. WILSGAARD; I. NJØLSTAD; L. JØRGENSEN; J.-B. 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 186 KB

Serum osteoprotegerin is increased in Cr

✍ Charles N Bernstein; Michael Sargent; William D Leslie 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB

A cohort study of the effects of serum o

✍ Thor Ueland; Scott G. Wilson; F. M. Amirul Islam; Ben Mullin; Amanda Devine; Jen 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 99 KB

Chronic kidney disease and cardiovascula

✍ NINOMIYA, TOSHIHARU; KIYOHARA, YUTAKA; KUBO, MICHIAKI; TANIZAKI, YUMIHIRO; DOI, 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 99 KB

Serum adiponectin concentration is a pos

✍ C. Forsblom; M. C. Thomas; J. Moran; M. Saraheimo; L. Thorn; J. Wadén; D. Gordin 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 217 KB